S. Gail Eckhardt

Currently, S.
Gail Eckhardt is Chairman at Albert & Margaret Alkek Foundation, Independent Director at Exelixis, Inc. since 2024, Director at Association of American Cancer Institutes since 2019, Director at OncoTEX Inc. since 2022, Director-Translational Research at Dan L.
Duncan Comprehensive Cancer Center, and Member of the National Academies Cancer Policy Forum.
Former roles include Director at Cancer Therapy & Research Center Endowment, Independent Director at NuGenerex Immuno-Oncology, Inc. from 2020 to 2021, Director-Livestrong Cancer at The University of Texas at Austin, Director at American Society of Clinical Oncology, Inc., Associate Director-Translational Research at The University of Colorado School of Medicine from 1999 to 2017, Associate Director at the University of Colorado Cancer Center, Associate Director at Synexus Clinical Research Us, Inc. (Arizona), Independent Director at Syros Pharmaceuticals, Inc. from 2020 to 2024, Professor at the University of Colorado Health Sciences Center, Scientific Advisor at 5AM Venture Management LLC, Chair-Oncology Department & Professor at Dell Medical School from 2017 to 2023, and Associate Dean-Experimental Therapeutics at Baylor College of Medicine.
Education includes undergraduate studies at Stephen F.
Austin State University and a doctorate from the University of Texas Medical Branch.